# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ernest Shackleton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX001-SYN-TD
- Date: 1921-05-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Cormac Ellingsworth-Daly, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for new patient visit for chest tightness and breathlessness on exertion in a heavy smoker planning a polar expedition: risk assessment, ECG and blood tests, starting treatment, smoking and alcohol counseling, and a cardiology referral. **S**

## Objective

Total cholesterol: 246 mg/dL (high); HDL cholesterol: 38 mg/dL (low); LDL cholesterol: 168 mg/dL (high); Triglycerides: 200 mg/dL (high); HbA1c: 5.9% (high); Potassium: 4.4 mmol/L; Creatinine: 0.98 mg/dL; ALT: 41 U/L; Hemoglobin: 15.8 g/dL; TSH: 1.9 mIU/L; eGFR: 96 mL/min/1.73 m²; PHQ-2: 1; AUDIT: 12. All results are synthetic.

BP 138/86 mmHg; pulse 78 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 86 kg; BMI 28.1 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Chest tightness and breathlessness on exertion for about three months, brought on by stairs, carrying loads, and walking fast in cold wind and relieved within minutes by rest, never at rest; resting ECG normal; cause not yet established at intake; coronary CT angiography and cardiology consultation requested; Nicotine dependence, cigarettes: about 25 a day since 16 (about 39 pack-years); Hyperlipidemia: LDL cholesterol 168 mg/dL and HDL 38 mg/dL at intake; Prediabetes: HbA1c 5.9% at intake. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Aspirin 81 mg delayed-release tablet, one tablet by mouth daily **S**
- Started: Atorvastatin 80 mg tablet, one tablet by mouth daily **S**
- Started: Metoprolol succinate extended-release 50 mg tablet, one tablet by mouth daily **S**
- Started: Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeat every 5 minutes up to 3 doses **S**
- Started: Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration **S**

## Plan

- Cardiology consultation in two weeks with coronary CT angiography for suspected stable angina, and advice on revascularization and on fitness for the expedition. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024) **S**
- Medical therapy from intake for suspected angina: aspirin 81 mg, atorvastatin 80 mg, metoprolol succinate, and sublingual nitroglycerin with written instructions to call emergency services if pain lasts more than 5 minutes after the first dose. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026) **S**
- Stop smoking: varenicline for 12 weeks, with the option of 12 more, a quit date in one week, counseling at each visit, and the quitline. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021) **S**
- AUDIT with a brief intervention for hazardous drinking: no more than two drinks a day and several alcohol-free days a week, with AUDIT-C at follow-up. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018) **S**
- Prediabetes: diet and activity counseling and HbA1c in about four months. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Prediabetes and Type 2 Diabetes: Screening (2021) **S**
